GoodRx Holdings, Inc. (GDRX)
Computer Software and Services • Information Technology
Financial Metrics
Price to Earnings75.37x
Revenue Growth (1Y)-1.83%
Debt to Equity0.76x
Strengths
Valuation
GoodRx Holdings, Inc. is overvalued
News
All
Press Releases
News
Filings

August 05, 2026GoodRx Reports Second Quarter 2026 Results

August 05, 202610-Q Quarterly Report for 2026 Q2

July 09, 2026
GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call

May 27, 2026GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs

May 06, 2026GoodRx Reports First Quarter 2026 Results

May 06, 202610-Q Quarterly Report for 2026 Q1

May 01, 2026GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients

April 17, 2026GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call

April 15, 2026GoodRx Rallies As Wegovy HD Rollout Targets Self-Pay Market

April 15, 2026GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price

April 09, 2026GoodRx Expands Access to Eli Lilly and Company’s New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide

March 11, 2026GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications

February 26, 202610-K Annual Report for 2025 FY

February 25, 2026GoodRx Reports Fourth Quarter and Full Year 2025 Results

February 24, 2026GoodRx Expands Into Employer Market With Launch of “GoodRx Employer Direct”

February 06, 2026GoodRx Powers Pricing for Leading Brand Medications on TrumpRx

February 02, 2026GoodRx Earns HITRUST i1 Certification for the Second Consecutive Year, Reinforcing Its Commitment to Protecting Healthcare Data at Scale

January 28, 2026
GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

January 13, 2026Surescripts and GoodRx Partner to Advance Patient Price Transparency

January 08, 2026GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies

January 05, 2026Novo Nordisk's Wegovy Weight Loss Pill Hits US Pharmacies With Lower Starting Cost

January 05, 2026GoodRx Now Offers Novo Nordisk’s Cash Price for the Launch of the Wegovy® Pill

December 16, 2025
GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference

November 17, 2025Novo Nordisk Leans Into Affordability Amid Rising Competition

November 17, 2025GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy®

November 04, 2025GoodRx Reports Third Quarter 2025 Results

November 04, 202510-Q Quarterly Report for 2025 Q3

October 15, 2025GoodRx Launches New Hair Loss Subscription for Men to Simplify Access to Affordable Treatment

October 09, 2025Trump Administration Engages Pharmacies, GoodRx For TrumpRx Launch

October 08, 2025
GoodRx Announces Date for Third Quarter 2025 Earnings Release and Conference Call

October 06, 2025GoodRx Expands Affordable Access to Repatha® with Nearly 60% Savings

October 01, 2025GoodRx Launches Brand Medication Savings Program at National Retail Pharmacy

September 02, 2025GoodRx Saddles Up With “The Savings Wrangler,” a Bold New Brand Campaign to Tame the Wild West of Prescription Pricing

August 19, 2025What's Going On With Hims & Hers Shares Today?

August 19, 2025Ozempic Gains First Approval In Canada For Kidney Disease And Cardiovascular Death Risk

August 19, 2025GoodRx Holdings Surges 5% After Hours on Novo Nordisk Partnership for $499 Monthly Ozempic, Wegovy Access

August 19, 2025Intel, Palo Alto Networks, Goodrx, Applied Digital And Duolingo: Why These 5 Stocks Are On Investors' Radars Today

August 18, 2025Stocks Muted Ahead Trump-Zelenskyy Meeting, First Solar Jumps: What's Moving Markets Monday?

August 18, 2025Crude Oil Moves Higher; US Homebuilder Sentiment Declines In August

August 18, 2025Ozempic And Wegovy Now Available Through GoodRx At Reduced Self-Pay Price, Stock Skyrockets

August 18, 2025GoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic® and Wegovy® for $499-Per-Month

August 06, 2025GoodRx Reports Second Quarter 2025 Results

August 06, 202510-Q Quarterly Report for 2025 Q2

July 28, 2025GoodRx Appoints Amazon Pharmacy Veteran Laura Jensen as President of Pharma Solutions

July 18, 2025
GOODRX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of GoodRx Holdings, Inc. - GDRX

July 09, 2025
GoodRx Announces Date for Second Quarter 2025 Earnings Release and Conference Call

May 07, 202510-Q Quarterly Report for 2025 Q1

February 27, 2025GoodRx Reports Mixed Q4: Pharma Strength Amid Subscription Decline, Sluggish Prescription Sales

February 27, 202510-K Annual Report for 2024 FY

November 07, 202410-Q Quarterly Report for 2024 Q3

August 08, 202410-Q Quarterly Report for 2024 Q2

May 09, 202410-Q Quarterly Report for 2024 Q1

February 29, 202410-K Annual Report for 2023 FY

November 09, 202310-Q Quarterly Report for 2023 Q3

August 09, 202310-Q Quarterly Report for 2023 Q2

May 10, 202310-Q Quarterly Report for 2023 Q1

March 01, 202310-K Annual Report for 2022 FY

November 09, 202210-Q Quarterly Report for 2022 Q3

August 09, 202210-Q Quarterly Report for 2022 Q2

May 10, 202210-Q Quarterly Report for 2022 Q1

March 01, 202210-K Annual Report for 2021 FY

November 12, 202110-Q Quarterly Report for 2021 Q3
A. Company Overview
GoodRx Holdings, Inc. is a healthcare technology company focused on enhancing the affordability and accessibility of healthcare services for consumers in the United States. Founded with the mission to assist Americans in obtaining necessary healthcare at a reasonable price, the company has developed a comprehensive, consumer-oriented digital platform. Initially starting as a price comparison tool for prescription medications, GoodRx has significantly expanded its offerings to include various healthcare services, telehealth solutions, and wellness-related content.
The company's platform processes a staggering volume of pricing data—over 320 billion pricing data points daily—integrating this information into a user-friendly interface that enables users to access geographically relevant prescription pricing. This system provides substantial savings on medications through negotiated prices, enabling consumers to utilize GoodRx codes at pharmacies nationwide. GoodRx has positioned itself as not only a cost-saving resource for consumers but also as a tool for improving overall health outcomes by increasing medication adherence and enabling quicker access to necessary treatments.
B. Industry Challenges
The U.S. healthcare market, valued at approximately $4.5 trillion, is characterized by significant consumer challenges, including a lack of transparency and fragmentation. Simple transactions such as filling prescriptions or finding affordable healthcare services are often complicated. Variabilities in medication pricing across pharmacies, coupled with a complex reimbursement landscape, contribute to consumer confusion and economic strain. GoodRx addresses this opacity by providing straightforward, accessible solutions that facilitate consumer engagement and empower informed healthcare decisions.
C. Market Opportunity
As consumers become increasingly cost-aware and informed, there is a growing market opportunity for platforms that enable transparent healthcare transactions. GoodRx estimates its total addressable market (TAM) between $534 billion and $607 billion, covering a broad spectrum of prescription opportunities. This includes approximately $515 billion to $588 billion specifically for prescriptions, and a $19 billion opportunity for solutions targeted at pharmaceutical manufacturers. By leveraging technology to present consumers with comprehensive data, GoodRx aims to streamline the healthcare purchasing process and enhance consumer efficiency.
D. Value Proposition
GoodRx creates significant value for multiple stakeholders in the healthcare ecosystem, including consumers, healthcare providers, pharmacy benefit managers (PBMs), pharmacies, and pharmaceutical manufacturers.
- Consumers: The platform offers various mobile-first solutions that help simplify and reduce healthcare costs, enhancing medication adherence and improving health outcomes.
- Healthcare Professionals: GoodRx empowers physicians by facilitating better patient engagement with price transparency and medication adherence support. Its provider tools integrate directly into electronic health record (EHR) systems, providing healthcare professionals with real-time pricing to enhance patient care.
- Healthcare Companies: PBMs and pharmacies benefit from increased traffic to their services through GoodRx's consumer platforms. The tool enhances market outreach and accessibility to their affordability solutions.
E. Offerings
GoodRx's offerings can be categorized into several key areas:
Prescription Marketplace
The cornerstone of GoodRx's service is its prescription marketplace, which includes:
- Prescription Transactions Offering: This feature aggregates pricing data from a multitude of sources, providing consumers with curated pricing information and enabling them to save significantly on medications. The platform maintains a high frequency of data updates and competitive pricing.
- Subscription Offerings: GoodRx Gold provides subscribers access to even lower prices, along with benefits like home delivery and telehealth services, enhancing consumer value without additional costs.
Pharma Manufacturer Solutions
GoodRx collaborates with pharmaceutical manufacturers to integrate affordability solutions (e.g., co-pay cards, patient assistance programs) into its platform, enhancing access for consumers while generating additional revenue through partnerships.
F. Growth Strategy
GoodRx's growth strategy entails several critical elements aimed at expanding its consumer base and enhancing its offerings:
- Consumer Acquisition: Continuous promotion of its existing offerings to attract new users, alongside efforts to improve brand awareness and education regarding prescription pricing.
- Monetization Channel Diversification: Encouraging existing consumers to engage with multiple GoodRx offerings to enhance satisfaction and lifetime value.
- Investment in Product Development: Committing resources to expand and enhance existing solutions, focusing on convenience and affordability for consumers.
- Strategic Partnerships and Acquisitions: Seeking relationships and partnerships across the healthcare ecosystem to amplify service offerings, and integrating innovative solutions that enhance consumer engagement.
G. Competition and Industry Participants
The competitive landscape for GoodRx is diverse, encompassing a range of both large and small organizations that provide similar prescription savings solutions. As the industry undergoes further consolidation, maintaining favorable agreements with PBMs and competing effectively against established players remains a priority for GoodRx.
H. Intellectual Property
GoodRx relies on a robust framework of intellectual property protections, including trademarks and patents, to shield its unique platform and offerings. The proprietary technology and data integration capabilities are key to its market position, enabling the company to offer a distinctive value proposition compared to competitors.
I. Philanthropy
The company actively engages in philanthropic initiatives through its "Good To Give" program, supporting numerous nonprofit organizations and encouraging employee participation in community service. Such efforts are part of GoodRx's broader commitment to corporate social responsibility and community engagement.
J. People and Culture
As a rapidly growing organization, GoodRx prioritizes its workforce, emphasizing a culture rooted in trust, empathy, and support. The company offers robust benefits and opportunities for professional development, cultivating an inclusive workplace environment across its operations.
Stock Infos
SectorInformation Technology
IndustryComputer Software and Services
CEOScott Wagner
Dividends

Digital Health Solutions
GoodRx provides a comprehensive digital platform that enhances the affordability and accessibility of healthcare services for consumers, focusing on medication pricing and adherence.

Telemedicine
Through its GoodRx Gold subscription offering, GoodRx provides services such as telehealth solutions which facilitate remote consultations and enhance consumer access to necessary healthcare.

Prescription Drug Providers
GoodRx functions as a marketplace for prescription medications, aggregating pricing data to offer consumers substantial savings on their prescriptions while directly facilitating transactions at pharmacies.

Pharmaceutical Companies
GoodRx collaborates with pharmaceutical manufacturers to integrate affordability solutions, like co-pay cards and patient assistance programs, into its platform to help consumers access medications more easily.

Data Advantage
The company leverages extensive data analytics to optimize pricing and offer personalized savings options for users, providing a significant edge over competitors who may not have access to such comprehensive data.